Baharaff Allen
SEC insider (Form 3/4/5 filer). CIK 0001630334. Chief Executive Officer at Galmed Pharmaceuticals Ltd. (GLMD). 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. Located in RAMAT GAN.
Companies Baharaff Allen has filed insider reports for
- Galmed Pharmaceuticals Ltd. (GLMD): Director, Officer, Chief Executive Officer
Baharaff Allen
CIK: 0001630334
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GLMD
Galmed Pharmaceuticals Ltd.
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions